Open this publication in new window or tab >>Show others...
2021 (English)In: Journal of Atrial Fibrillation, ISSN 1941-6911, Vol. 14, no 1, article id 20200454Article in journal (Refereed) Published
Abstract [en]
Background: Radiofrequency ablation (RFA)is an important treatment option for patients with atrial fibrillation (AF). During RFA, a significant amount of energy is delivered into the left atrium (LA), resulting in considerable LA-injury. The impact of this damage on mechanical and endocrine LA-function, however, is often disregarded.We therefore aimed to evaluate the endocrine- and mechanical function of the heart 4-months after RFA of AF.
Methods: In total 189 patients eligible for RFA of AF were studied. The levels of the N-terminal pro-B-natriuretic peptide (NT-proBNP) and the mid-regional fragment of the N-terminal pro-atrial natriuretic peptide (MR-proANP)were measured. The maximum LAvolume (LAVmax),the LAejection fraction (LAEF) and the LA peak longitudinal strain (PALS), were measured usingtransthoracic echocardiography. The measurements were performed before and 4-months after the intervention.
Results: 87 patients had a recurrence during a mean follow-up of 143±36 days.NT-proBNPand MR-proANPdecreased significantly at follow-up. This reduction was greater in patients who did not suffer any recurrence after RFA.The LAVmax decreased significantly, whereasthe PALS only improved in patients who did not suffer from any recurrence. On the other hand, LAEF did not change significantly after RFA of AF.
Conclusions: Despite extensiveablation during RFA of AF, the endocrine function of the heart improved 4-months after the index procedure. Patients with no arrhythmia recurrence showed a more pronounced improvement in their endocrinal function. Mechanically, the LAVmax was reduced, and the LA strain improved significantly.
Place, publisher, year, edition, pages
Overland Park, KS, United States: Cardiofront, Inc, 2021
Keywords
Atrial fibrillation, Left Atrial Ejection Fraction, Left Atrial Strain, Natriuretic Peptides, Radiofrequency Ablation
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:liu:diva-184177 (URN)10.4022/jafib.20200454 (DOI)34950357 (PubMedID)
Note
Funding: This study was supported by grants from the County Council of Östergötland, the Carldavid Jönsson Research Foundation, the Heart Foundation, Linköping University and by unrestricted grants from Biosense Webster, Johnson & Johnson.
2022-04-062022-04-062022-04-14Bibliographically approved